Localisation barriers to trade in the biopharmaceutical industry
Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.
Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.